Efficient lentiviral transduction and improved engraftment of human bone marrow mesenchymal cells

Stem Cells

Volumn 24, Issue 4, 2006, Pages 896-907

  Van Damme, A N ^a   Thorrez, Lieven ^a   Ma, Ling ^a   Vandenburgh, Herman ^a,d   Eyckmans, Jeroen ^b   Dell'Accio, Francesco ^b   De Bari, Cosimo ^b   Luyten, Frank ^b   Lillicrap, David ^c   Collen, Désiré ^a   VandenDriessche, Thierry ^a   Chuah, Marinee K L ^a  

^a DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

^b UNIVERSITY OF LEUVEN   (Belgium)

^c QUEEN S UNIVERSITY   (Canada)

^d BROWN UNIVERSITY   (United States)

Author keywords

Bone marrow; Lentiviral; Mesenchymal cell

Indexed keywords

BLOOD CLOTTING FACTOR 8; COLLAGEN; GREEN FLUORESCENT PROTEIN; LENTIVIRUS VECTOR; MESSENGER RNA; RETROVIRUS VECTOR; DNA; F8 PROTEIN, HUMAN; RECOMBINANT PROTEIN;

ADIPOGENESIS; ARTICLE; BIOCOMPATIBILITY; BIOENGINEERING; BIOSAFETY; BONE DEVELOPMENT; BONE MARROW CELL; BONE MARROW TRANSPLANTATION; CELL DIFFERENTIATION; CELL LINEAGE; CELL TRANSPLANTATION; CONTROLLED STUDY; CYTOMEGALOVIRUS; DRUG TARGETING; EVALUATION; EX VIVO STUDY; EXPRESSION VECTOR; GENE EXPRESSION; GENE TRANSFER; GENETIC ENGINEERING; GENETIC TRANSDUCTION; HUMAN; HUMAN CELL; IMMUNE DEFICIENCY; IN VITRO STUDY; IN VIVO STUDY; INTERMETHOD COMPARISON; MEASUREMENT; MESENCHYME CELL; POLYMERASE CHAIN REACTION; PROMOTER REGION; PROTEIN EXPRESSION; SOUTHERN BLOTTING; TARGET CELL; TRANSGENE; VIRAL GENE DELIVERY SYSTEM; VIRAL GENE THERAPY; BIOMEDICAL ENGINEERING; CELL CULTURE; CYTOLOGY; GENE THERAPY; GENETICS; GRAFT SURVIVAL; HEMATOPOIETIC STEM CELL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; LENTIVIRINAE; MESENCHYMAL STEM CELL; MESENCHYMAL STEM CELL TRANSPLANTATION; METABOLISM; METHODOLOGY; NUCLEOTIDE SEQUENCE;

CYTOMEGALOVIRUS;

ADIPOGENESIS; BASE SEQUENCE; BIOMEDICAL ENGINEERING; CELL DIFFERENTIATION; CELLS, CULTURED; DNA; FACTOR VIII; GENE THERAPY; GRAFT SURVIVAL; GREEN FLUORESCENT PROTEINS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMATOPOIETIC STEM CELLS; HUMANS; LENTIVIRUS; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STEM CELLS; OSTEOGENESIS; RECOMBINANT PROTEINS; RNA, MESSENGER; TRANSDUCTION, GENETIC;

EID: 33745512338     PISSN: 10665099     EISSN: None     Source Type: Journal    
DOI: 10.1634/stemcells.2003-0106     Document Type: Article

References (38)

1. Van Damme A, Vanden Driessche T, Collen D et al. Bone marrow stromal cells as targets for gene therapy. Curr Gene Ther 2002;2:195-209.
2. Pittenger MF, Mackay AM, Beck SC et al. Multilineage potential of adult human mesenchymal stem cells. Science 1999;284:143-146.
3. Reyes M, Lund T, Lenvik T et al. Purification and ex vivo expansion of postnatal human marrow mesodermal progenitor cells. Blood 2001;98:2615-2625.
4. Jiang Y, Jahagirdar BN, Reinhardt RL et al. Pluripotency of mesenchymal stem cells derived from adult marrow. Nature 2002;418:41-49.
5. Chuah MK, Van Damme A, Zwinnen H et al. Long-term persistence of human bone marrow stromal cells transduced with factor VIII-retroviral vectors and transient production of therapeutic levels of human factor VIII in nonmyeloablated immunodeficient mice. Hum Gene Ther 2000;11:729-738.
6. Van Damme A, Chuah MK, Dell'accio F et al. Bone marrow mesenchymal cells for haemophilia. A gene therapy using retroviral vectors with modified long-terminal repeats. Haemophilia 2003;9:94-103.
7. Nolta JA, Hanley MB, Kohn DB. Sustained human hematopoiesis in immunodeficient mice by cotransplantation of marrow stroma expressing human interleukin-3: Analysis of gene transduction of long-lived progenitors. Blood 1994;83:3041-3051.
8. Lee K, Majumdar MK, Buyaner D et al. Human mesenchymal stem cells maintain transgene expression during expansion and differentiation. Mol Ther 2001;3:857-866.
9. Rombouts WJ, Ploemacher RE. Primary murine MSC show highly efficient homing to the bone marrow but lose homing ability following culture. Leukemia 2003;17:160-170.
10. + cells that mediate long-term engraftment of NOD/SCID mice by HIV vectors. Science 1999;283:682-686.
11. Pfeifer A, Ikawa M, Dayn Y et al. Transgenesis by lentiviral vectors: Lack of gene silencing in mammalian embryonic stem cells and preimplantation embryos. Proc Natl Acad Sci U S A 2002;99:2140-2145.
12. Pereboeva L, Komarova S, Mikheeva G et al. Approaches to utilize mesenchymal progenitor cells as cellular vehicles. STEM CELLS 2003;21:389-404.
13. Challita PM, Skelton D, el-Khoueiry A et al. Multiple modifications in cis elements of the long terminal repeat of retroviral vectors lead to increased expression and decreased DNA methylation in embryonic carcinoma cells. J Virol 1995;69:748-755.
14. VandenDriessche T, Vanslembrouck V, Goovaerts I et al. Long-term expression of human coagulation factor VIII and correction of hemophilia A after in vivo retroviral gene transfer in factor VIII-deficient mice. Proc Natl Acad Sci U S A 1999;96:10379-10384.
15. Follenzi A, Ailles LE, Bakovic S et al. Gene transfer by lentiviral vectors is limited by nuclear translocation and rescued by HIV-1 pol sequences. Nat Genet 2000;25:217-222.
16. VandenDriessche T, Thorrez L, Naldini L et al. Lentiviral vectors containing the human immunodeficiency virus type-1 central polypurine tract can efficiently transduce nondividing hepatocytes and antigen-presenting cells in vivo. Blood 2002;100:813-822.
17. Zufferey R, Dull T, Mandel RJ et al. Self-inactivating lentivirus vector for safe and efficient in vivo gene delivery. J Virol 1998;72:9873-9880.
18. Cameron C, Notley C, Hoyle S et al. The canine factor VIII cDNA and 5′ flanking sequence. Thromb Haemost 1998;79:317-322.
19. Dull T, Zufferey R, Kelly M et al. A third-generation lentivirus vector with a conditional packaging system. J Virol 1998;72:8463-8471.
20. Zufferey R, Nagy D, Mandel RJ et al. Multiply attenuated lentiviral vector achieves efficient gene delivery in vivo. Nature Biotechnol 1997;15:871-875.
21. Chuah MK, Vandendriessche T, Morgan RA. Development and analysis of retroviral vectors expressing human factor VIII as a potential gene therapy for hemophilia A. Hum Gene Ther 1995;6:1363-1377.
22. De Bari C, Dell'Accio F, Tylzanowski P et al. Multipotent mesenchymal stem cells from adult human synovial membrane. Arthritis Rheum 2001;44:1928-1942.
23. Powell C, Shansky J, Del Tatto M et al. Tissue-engineered human bioartificial muscles expressing a foreign recombinant protein for gene therapy. Hum Gene Ther 1999;10:565-577.
24. Chuah MK, Brems H, Vanslembrouck V et al. Bone marrow stromal cells as targets for gene therapy of hemophilia A. Hum Gene Ther 1998;9:353-365.
25. Zhang XY, La Russa VF, Bao L et al. Lentiviral vectors for sustained transgene expression in human bone marrow-derived stromal cells. Mol Ther 2002;5:555-565.
26. Sirven A, Pflumio F, Zennou V et al. The human immunodeficiency virus type-1 central DNA flap is a crucial determinant for lentiviral vector nuclear import and gene transduction of human hematopoietic stem cells. Blood 2000;96:4103-4110.
27. Stevenson M. HIV nuclear import: What's the flap? Nat Med 2000;6:626-628.
28. Hacein-Bey-Abina S, von Kalle C, Schmidt M et al. A serious adverse event after successful gene therapy for X-linked severe combined immunodeficiency. N Engl J Med 2003;348:255-256.
29. Baum C, Dullmann J, Li Z et al. Side effects of retroviral gene transfer into hematopoietic stem cells. Blood 2003;101:2099-2114.
30. Ramezani A, Hawley TS, Hawley RG. Performance- and safety-enhanced lentiviral vectors containing the human interferon-β scaffold attachment region and the chicken β-globin insulator. Blood 2003;101:4717-4724.
31. Woods NB, Muessig A, Schmidt M et al. Lentiviral vector transduction of NOD/SCID repopulating cells results in multiple vector integrations per transduced cell: Risk of insertional mutagenesis. Blood 2003;101:1284-1289.
32. Conget PA, Minguell JJ. Adenoviral-mediated gene transfer into ex vivo expanded human bone marrow mesenchymal progenitor cells. Exp Hematol 2000;28:382-390.
33. Saenz DT, Loewen N, Peretz M et al. Unintegrated lentivirus DNA persistence and accessibility to expression in nondividing cells: Analysis with class I integrase mutants. J Virol 2004;78:2906-2920.
34. Banfi A, Bianchi G, Notaro R et al. Replicative aging and gene expression in long-term cultures of human bone marrow stromal cells. Tissue Eng 2002;8:901-910.
35. Rosenqvist N, Hard Af Segerstad C, Samuelsson C et al. Activation of silenced transgene expression in neural precursor cell lines by inhibitors of histone deacetylation. J Gene Med 2002;4:248-257.
36. Hanazono Y, Yu JM, Dunbar CE et al. Green fluorescent protein retroviral vectors: Low titer and high recombination frequency suggest a selective disadvantage. Hum Gene Ther 1997;8:1313-1319.
37. Martinez-Serrano A, Villa A, Navarro B et al. Human neural progenitor cells: Better blue than green? Nat Med 2000;6:483-484.
38. Sekiya I, Larson BL, Smith JR et al. Expansion of human adult stem cells from bone marrow stroma: Conditions that maximize the yields of early progenitors and evaluate their quality. STEM CELLS 2002;20:530-541.